Page last updated: 2024-11-06

6-paradol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

6-Paradol is a natural phenolic compound found in ginger (Zingiber officinale) and other plants. It is known for its anti-inflammatory, antioxidant, and analgesic properties. Research suggests that 6-paradol may have potential therapeutic effects in various conditions, including cancer, arthritis, and diabetes. It is studied for its potential to inhibit inflammatory pathways, reduce oxidative stress, and modulate immune responses. Synthesis of 6-paradol can be achieved through various methods, including extraction from ginger, chemical synthesis, and enzymatic synthesis.'

6-paradol: induces apoptosis; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID94378
CHEMBL ID2071440
CHEBI ID10137
SCHEMBL ID971599
MeSH IDM0380782

Synonyms (51)

Synonym
HY-14617
[6]-paradol
ACON1_001067
paradol
einecs 248-228-1
brn 1984119
1-(4-hydroxy-3-methoxyphenyl)-3-decanone
5-paradol
1-(4-hydroxy-3-methoxyphenyl)decan-5-one
MEGXP0_001218
6-paradol
3-decanone, 1-(4-hydroxy-3-methoxyphenyl)-
27113-22-0
NCGC00169709-01
BRD-K84571636-001-01-4
1-(4-hydroxy-3-methoxyphenyl)decan-3-one
unii-bo24id7e9u
bo24id7e9u ,
2-08-00-00318 (beilstein handbook reference)
ccris 8519
1-(4-hydroxy-3-methoxy-phenyl)decan-3-one
CS-0873
hydroxymethoxyphenyl decanone [inci]
(6)-paradol
(6)-gingerone
hydroxymethoxyphenyl decanone
6-gingerone
fema no. 4665
1-(4-hydroxy-3-methoxyphenyl)-decan-3-one
heptyl 4-hydroxy-3-methoxyphenethyl ketone
chebi:10137 ,
CHEMBL2071440 ,
S5551
SCHEMBL971599
[6]-gingerone
1-(4-hydroxy-3-methoxyphenyl)-3-decanone #
bdbm50237535
DTXSID90181574
AKOS028111088
AS-64448
mfcd01736103
BCP24208
Q3363309
1-(4'-hydroxy-3'-methoxyphenyl)-decan-3-one
1-(4'-hydroxy-3'-methoxyphenyl)-3-decanone
CCG-267231
FT-0775579
A911271
EX-A6738
[6]-gingerone;[6]-paradol
AC-36782

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The method for validation following oral administration of ZR and ZRC to rats was proved to be a success in the pharmacokinetic study of the seven ingredients."( A network pharmacology integrated pharmacokinetics strategy to investigate the pharmacological mechanism of absorbed components from crude and processed Zingiberis Rhizoma on deficiency-cold and hemorrhagic syndrome.
Cao, H; Li, J; Li, W; Liu, S; Meng, J; Sun, Y; Wang, S; Zhang, Y, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
ketoneA compound in which a carbonyl group is bonded to two carbon atoms: R2C=O (neither R may be H).
monomethoxybenzeneCompounds containing a benzene skeleton substituted with one methoxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (9)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Cytochrome P450 1A2Homo sapiens (human)IC50 (µMol)21.40000.00011.774010.0000AID1443014
Cytochrome P450 2E1Homo sapiens (human)IC50 (µMol)21.40000.01401.68726.2000AID1443014
Cytochrome P450 3A4Homo sapiens (human)IC50 (µMol)8.15000.00011.753610.0000AID1443017; AID1443018
Cytochrome P450 2C8Homo sapiens (human)IC50 (µMol)4.80000.00081.88487.9000AID1443016; AID1443018
Cytochrome P450 2D6Homo sapiens (human)IC50 (µMol)3.80000.00002.015110.0000AID1443016
Cytochrome P450 2A6Homo sapiens (human)IC50 (µMol)10.50000.00443.889510.0000AID1443017
Cytochrome P450 2C9 Homo sapiens (human)IC50 (µMol)10.50000.00002.800510.0000AID1443017
Cytochrome P450 2B6Homo sapiens (human)IC50 (µMol)6.20000.00113.418610.0000AID1443015
Cytochrome P450 2C19Homo sapiens (human)IC50 (µMol)5.80000.00002.398310.0000AID1443018
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (50)

Processvia Protein(s)Taxonomy
steroid catabolic processCytochrome P450 1A2Homo sapiens (human)
porphyrin-containing compound metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 1A2Homo sapiens (human)
cholesterol metabolic processCytochrome P450 1A2Homo sapiens (human)
estrogen metabolic processCytochrome P450 1A2Homo sapiens (human)
toxin biosynthetic processCytochrome P450 1A2Homo sapiens (human)
post-embryonic developmentCytochrome P450 1A2Homo sapiens (human)
alkaloid metabolic processCytochrome P450 1A2Homo sapiens (human)
regulation of gene expressionCytochrome P450 1A2Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 1A2Homo sapiens (human)
dibenzo-p-dioxin metabolic processCytochrome P450 1A2Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
lung developmentCytochrome P450 1A2Homo sapiens (human)
methylationCytochrome P450 1A2Homo sapiens (human)
monocarboxylic acid metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 1A2Homo sapiens (human)
retinol metabolic processCytochrome P450 1A2Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 1A2Homo sapiens (human)
cellular respirationCytochrome P450 1A2Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 1A2Homo sapiens (human)
hydrogen peroxide biosynthetic processCytochrome P450 1A2Homo sapiens (human)
oxidative demethylationCytochrome P450 1A2Homo sapiens (human)
cellular response to cadmium ionCytochrome P450 1A2Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
long-chain fatty acid metabolic processCytochrome P450 2E1Homo sapiens (human)
lipid hydroxylationCytochrome P450 2E1Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2E1Homo sapiens (human)
steroid metabolic processCytochrome P450 2E1Homo sapiens (human)
response to bacteriumCytochrome P450 2E1Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 2E1Homo sapiens (human)
carbon tetrachloride metabolic processCytochrome P450 2E1Homo sapiens (human)
benzene metabolic processCytochrome P450 2E1Homo sapiens (human)
4-nitrophenol metabolic processCytochrome P450 2E1Homo sapiens (human)
halogenated hydrocarbon metabolic processCytochrome P450 2E1Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 2E1Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2E1Homo sapiens (human)
lipid hydroxylationCytochrome P450 3A4Homo sapiens (human)
lipid metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid catabolic processCytochrome P450 3A4Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid metabolic processCytochrome P450 3A4Homo sapiens (human)
cholesterol metabolic processCytochrome P450 3A4Homo sapiens (human)
androgen metabolic processCytochrome P450 3A4Homo sapiens (human)
estrogen metabolic processCytochrome P450 3A4Homo sapiens (human)
alkaloid catabolic processCytochrome P450 3A4Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 3A4Homo sapiens (human)
calcitriol biosynthetic process from calciolCytochrome P450 3A4Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D metabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D catabolic processCytochrome P450 3A4Homo sapiens (human)
retinol metabolic processCytochrome P450 3A4Homo sapiens (human)
retinoic acid metabolic processCytochrome P450 3A4Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 3A4Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 3A4Homo sapiens (human)
oxidative demethylationCytochrome P450 3A4Homo sapiens (human)
lipid hydroxylationCytochrome P450 2C8Homo sapiens (human)
organic acid metabolic processCytochrome P450 2C8Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2C8Homo sapiens (human)
steroid metabolic processCytochrome P450 2C8Homo sapiens (human)
estrogen metabolic processCytochrome P450 2C8Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2C8Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2C8Homo sapiens (human)
retinol metabolic processCytochrome P450 2C8Homo sapiens (human)
retinoic acid metabolic processCytochrome P450 2C8Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 2C8Homo sapiens (human)
icosanoid biosynthetic processCytochrome P450 2C8Homo sapiens (human)
oxidative demethylationCytochrome P450 2C8Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 2C8Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2D6Homo sapiens (human)
steroid metabolic processCytochrome P450 2D6Homo sapiens (human)
cholesterol metabolic processCytochrome P450 2D6Homo sapiens (human)
estrogen metabolic processCytochrome P450 2D6Homo sapiens (human)
coumarin metabolic processCytochrome P450 2D6Homo sapiens (human)
alkaloid metabolic processCytochrome P450 2D6Homo sapiens (human)
alkaloid catabolic processCytochrome P450 2D6Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 2D6Homo sapiens (human)
isoquinoline alkaloid metabolic processCytochrome P450 2D6Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2D6Homo sapiens (human)
retinol metabolic processCytochrome P450 2D6Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 2D6Homo sapiens (human)
negative regulation of bindingCytochrome P450 2D6Homo sapiens (human)
oxidative demethylationCytochrome P450 2D6Homo sapiens (human)
negative regulation of cellular organofluorine metabolic processCytochrome P450 2D6Homo sapiens (human)
arachidonic acid metabolic processCytochrome P450 2D6Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2A6Homo sapiens (human)
steroid metabolic processCytochrome P450 2A6Homo sapiens (human)
coumarin metabolic processCytochrome P450 2A6Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2A6Homo sapiens (human)
coumarin catabolic processCytochrome P450 2A6Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2A6Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2C9 Homo sapiens (human)
steroid metabolic processCytochrome P450 2C9 Homo sapiens (human)
cholesterol metabolic processCytochrome P450 2C9 Homo sapiens (human)
estrogen metabolic processCytochrome P450 2C9 Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 2C9 Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2C9 Homo sapiens (human)
urea metabolic processCytochrome P450 2C9 Homo sapiens (human)
monocarboxylic acid metabolic processCytochrome P450 2C9 Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2C9 Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 2C9 Homo sapiens (human)
amide metabolic processCytochrome P450 2C9 Homo sapiens (human)
icosanoid biosynthetic processCytochrome P450 2C9 Homo sapiens (human)
oxidative demethylationCytochrome P450 2C9 Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 2C9 Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2B6Homo sapiens (human)
steroid metabolic processCytochrome P450 2B6Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2B6Homo sapiens (human)
cellular ketone metabolic processCytochrome P450 2B6Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2B6Homo sapiens (human)
long-chain fatty acid metabolic processCytochrome P450 2C19Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2C19Homo sapiens (human)
steroid metabolic processCytochrome P450 2C19Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 2C19Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2C19Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2C19Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 2C19Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (41)

Processvia Protein(s)Taxonomy
monooxygenase activityCytochrome P450 1A2Homo sapiens (human)
iron ion bindingCytochrome P450 1A2Homo sapiens (human)
protein bindingCytochrome P450 1A2Homo sapiens (human)
electron transfer activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 1A2Homo sapiens (human)
enzyme bindingCytochrome P450 1A2Homo sapiens (human)
heme bindingCytochrome P450 1A2Homo sapiens (human)
demethylase activityCytochrome P450 1A2Homo sapiens (human)
caffeine oxidase activityCytochrome P450 1A2Homo sapiens (human)
aromatase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
hydroperoxy icosatetraenoate dehydratase activityCytochrome P450 1A2Homo sapiens (human)
monooxygenase activityCytochrome P450 2E1Homo sapiens (human)
iron ion bindingCytochrome P450 2E1Homo sapiens (human)
oxidoreductase activityCytochrome P450 2E1Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygenCytochrome P450 2E1Homo sapiens (human)
4-nitrophenol 2-monooxygenase activityCytochrome P450 2E1Homo sapiens (human)
oxygen bindingCytochrome P450 2E1Homo sapiens (human)
enzyme bindingCytochrome P450 2E1Homo sapiens (human)
heme bindingCytochrome P450 2E1Homo sapiens (human)
Hsp70 protein bindingCytochrome P450 2E1Homo sapiens (human)
Hsp90 protein bindingCytochrome P450 2E1Homo sapiens (human)
aromatase activityCytochrome P450 2E1Homo sapiens (human)
long-chain fatty acid omega-1 hydroxylase activityCytochrome P450 2E1Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2E1Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2E1Homo sapiens (human)
monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
steroid bindingCytochrome P450 3A4Homo sapiens (human)
iron ion bindingCytochrome P450 3A4Homo sapiens (human)
protein bindingCytochrome P450 3A4Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
retinoic acid 4-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
oxidoreductase activityCytochrome P450 3A4Homo sapiens (human)
oxygen bindingCytochrome P450 3A4Homo sapiens (human)
enzyme bindingCytochrome P450 3A4Homo sapiens (human)
heme bindingCytochrome P450 3A4Homo sapiens (human)
vitamin D3 25-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
caffeine oxidase activityCytochrome P450 3A4Homo sapiens (human)
quinine 3-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
testosterone 6-beta-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 8,9 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 11,12 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 14,15 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
aromatase activityCytochrome P450 3A4Homo sapiens (human)
vitamin D 24-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1,8-cineole 2-exo-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
monooxygenase activityCytochrome P450 2C8Homo sapiens (human)
iron ion bindingCytochrome P450 2C8Homo sapiens (human)
protein bindingCytochrome P450 2C8Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2C8Homo sapiens (human)
retinoic acid 4-hydroxylase activityCytochrome P450 2C8Homo sapiens (human)
caffeine oxidase activityCytochrome P450 2C8Homo sapiens (human)
aromatase activityCytochrome P450 2C8Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 2C8Homo sapiens (human)
heme bindingCytochrome P450 2C8Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2C8Homo sapiens (human)
monooxygenase activityCytochrome P450 2D6Homo sapiens (human)
iron ion bindingCytochrome P450 2D6Homo sapiens (human)
oxidoreductase activityCytochrome P450 2D6Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2D6Homo sapiens (human)
heme bindingCytochrome P450 2D6Homo sapiens (human)
anandamide 8,9 epoxidase activityCytochrome P450 2D6Homo sapiens (human)
anandamide 11,12 epoxidase activityCytochrome P450 2D6Homo sapiens (human)
anandamide 14,15 epoxidase activityCytochrome P450 2D6Homo sapiens (human)
iron ion bindingCytochrome P450 2A6Homo sapiens (human)
coumarin 7-hydroxylase activityCytochrome P450 2A6Homo sapiens (human)
enzyme bindingCytochrome P450 2A6Homo sapiens (human)
heme bindingCytochrome P450 2A6Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2A6Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2A6Homo sapiens (human)
monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
iron ion bindingCytochrome P450 2C9 Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2C9 Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 2C9 Homo sapiens (human)
arachidonic acid 14,15-epoxygenase activityCytochrome P450 2C9 Homo sapiens (human)
arachidonic acid 11,12-epoxygenase activityCytochrome P450 2C9 Homo sapiens (human)
oxidoreductase activityCytochrome P450 2C9 Homo sapiens (human)
(S)-limonene 6-monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
(S)-limonene 7-monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
caffeine oxidase activityCytochrome P450 2C9 Homo sapiens (human)
(R)-limonene 6-monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
aromatase activityCytochrome P450 2C9 Homo sapiens (human)
heme bindingCytochrome P450 2C9 Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2C9 Homo sapiens (human)
monooxygenase activityCytochrome P450 2B6Homo sapiens (human)
iron ion bindingCytochrome P450 2B6Homo sapiens (human)
testosterone 16-alpha-hydroxylase activityCytochrome P450 2B6Homo sapiens (human)
heme bindingCytochrome P450 2B6Homo sapiens (human)
testosterone 16-beta-hydroxylase activityCytochrome P450 2B6Homo sapiens (human)
anandamide 8,9 epoxidase activityCytochrome P450 2B6Homo sapiens (human)
anandamide 11,12 epoxidase activityCytochrome P450 2B6Homo sapiens (human)
anandamide 14,15 epoxidase activityCytochrome P450 2B6Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 2B6Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2B6Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2B6Homo sapiens (human)
monooxygenase activityCytochrome P450 2C19Homo sapiens (human)
iron ion bindingCytochrome P450 2C19Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 2C19Homo sapiens (human)
oxidoreductase activityCytochrome P450 2C19Homo sapiens (human)
(S)-limonene 6-monooxygenase activityCytochrome P450 2C19Homo sapiens (human)
(S)-limonene 7-monooxygenase activityCytochrome P450 2C19Homo sapiens (human)
oxygen bindingCytochrome P450 2C19Homo sapiens (human)
enzyme bindingCytochrome P450 2C19Homo sapiens (human)
heme bindingCytochrome P450 2C19Homo sapiens (human)
(R)-limonene 6-monooxygenase activityCytochrome P450 2C19Homo sapiens (human)
aromatase activityCytochrome P450 2C19Homo sapiens (human)
long-chain fatty acid omega-1 hydroxylase activityCytochrome P450 2C19Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2C19Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2C19Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (8)

Processvia Protein(s)Taxonomy
endoplasmic reticulum membraneCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
mitochondrial inner membraneCytochrome P450 2E1Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2E1Homo sapiens (human)
cytoplasmCytochrome P450 2E1Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2E1Homo sapiens (human)
cytoplasmCytochrome P450 3A4Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 3A4Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 3A4Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2C8Homo sapiens (human)
plasma membraneCytochrome P450 2C8Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C8Homo sapiens (human)
cytoplasmCytochrome P450 2C8Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C8Homo sapiens (human)
mitochondrionCytochrome P450 2D6Homo sapiens (human)
endoplasmic reticulumCytochrome P450 2D6Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2D6Homo sapiens (human)
cytoplasmCytochrome P450 2D6Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2D6Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2A6Homo sapiens (human)
cytoplasmic microtubuleCytochrome P450 2A6Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2A6Homo sapiens (human)
cytoplasmCytochrome P450 2A6Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2C9 Homo sapiens (human)
plasma membraneCytochrome P450 2C9 Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C9 Homo sapiens (human)
cytoplasmCytochrome P450 2C9 Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C9 Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2B6Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2B6Homo sapiens (human)
cytoplasmCytochrome P450 2B6Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2C19Homo sapiens (human)
plasma membraneCytochrome P450 2C19Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C19Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C19Homo sapiens (human)
cytoplasmCytochrome P450 2C19Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (155)

Assay IDTitleYearJournalArticle
AID1219957Induction of apoptosis in human HCT116 cells assessed as apoptotic cells at 40 uM after 24 hrs by TUNEL assay2012Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 40, Issue:4
Metabolism of [6]-shogaol in mice and in cancer cells.
AID1442905Inhibition of CYP2B6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 3 uM using bupropion as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442963Inhibition of CYP2A6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 30 uM using coumarin as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis r2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442912Inhibition of CYP2C8 in human liver microsomes assessed as enzyme-mediated metabolite formation at 3 uM using paclitaxel as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1443013Inhibition of CYP3A4 in human liver microsomes using testosterone as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442979Inhibition of CYP2C9 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.1 uM using diclofenac as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysi2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442999Inhibition of CYP2D6 in human liver microsomes using dextromethorphan as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1219993Drug level in human HT-29 cells treated with 10 uM [6]-shogaol by HPLC-ECD analysis2012Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 40, Issue:4
Metabolism of [6]-shogaol in mice and in cancer cells.
AID1442960Inhibition of CYP2A6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 1 uM using coumarin as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis re2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442946Inhibition of CYP3A4 in human liver microsomes assessed as enzyme-mediated metabolite formation at 1 uM using testosterone as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442974Inhibition of CYP2C8 in human liver microsomes assessed as enzyme-mediated metabolite formation at 1 uM using paclitaxel as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis 2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1443010Inhibition of CYP3A4 in human liver microsomes assessed as enzyme-mediated metabolite formation at 3 uM using testosterone as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysi2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1443014Inhibition of human CYP1A2 using phenacetin as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442948Inhibition of CYP3A4 in human liver microsomes assessed as enzyme-mediated metabolite formation at 10 uM using testosterone as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442978Inhibition of CYP2C8 in human liver microsomes using paclitaxel as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442937Inhibition of CYP3A4 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.1 uM using midazolam as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442985Inhibition of CYP2C9 in human liver microsomes using diclofenac as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442929Inhibition of CYP2C19 in human liver microsomes assessed as enzyme-mediated metabolite formation using (S)-mephenytoin as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID676748Inhibition of Multidrug resistance efflux pump in Mycobacterium smegmatis str. MC2 155 ATCC 700084 assessed as reduction in isoniazid bromide MIC presence of test compound at 16 mg/L2012Journal of natural products, Jul-27, Volume: 75, Issue:7
Putative mycobacterial efflux inhibitors from the seeds of Aframomum melegueta.
AID1219958Induction of apoptosis in human H1299 cells assessed as apoptotic cells at 40 uM after 24 hrs by TUNEL assay2012Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 40, Issue:4
Metabolism of [6]-shogaol in mice and in cancer cells.
AID1442927Inhibition of CYP2C19 in human liver microsomes assessed as enzyme-mediated metabolite formation at 10 uM using (S)-mephenytoin as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442938Inhibition of CYP3A4 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.3 uM using midazolam as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1220000Cytotoxicity against human HCT116 cells assessed as growth inhibition after 24 hrs by MTT assay2012Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 40, Issue:4
Metabolism of [6]-shogaol in mice and in cancer cells.
AID1442900Inhibition of CYP2A6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 30 uM using coumarin as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID676736Antimicrobial activity against Mycobacterium smegmatis str. MC2 155 ATCC 700084 incubated for 72 hrs in 7H9 T medium supplemented with 10% Middlebrook ADC enrichment by MTT assay2012Journal of natural products, Jul-27, Volume: 75, Issue:7
Putative mycobacterial efflux inhibitors from the seeds of Aframomum melegueta.
AID1443007Inhibition of CYP3A4 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.1 uM using testosterone as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analy2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442915Inhibition of CYP2C8 in human liver microsomes assessed as enzyme-mediated metabolite formation using paclitaxel as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442939Inhibition of CYP3A4 in human liver microsomes assessed as enzyme-mediated metabolite formation at 1 uM using midazolam as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442944Inhibition of CYP3A4 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.1 uM using testosterone as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442894Inhibition of CYP1A2 in human liver microsomes assessed as enzyme-mediated metabolite formation at 30 uM using phenacetin as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442908Inhibition of CYP2B6 in human liver microsomes assessed as enzyme-mediated metabolite formation using bupropion as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1443011Inhibition of CYP3A4 in human liver microsomes assessed as enzyme-mediated metabolite formation at 10 uM using testosterone as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analys2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442911Inhibition of CYP2C8 in human liver microsomes assessed as enzyme-mediated metabolite formation at 1 uM using paclitaxel as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID676756Inhibition of Multidrug resistance efflux pump in Mycobacterium smegmatis str. MC2 155 ATCC 700084 assessed as increase in normalized ethidium bromide fluorescence efflux at 0.5 MIC level by fluorimetric assay (Rvb = 0.581 +/- 0.051 ratio)2012Journal of natural products, Jul-27, Volume: 75, Issue:7
Putative mycobacterial efflux inhibitors from the seeds of Aframomum melegueta.
AID1442936Inhibition of CYP2D6 in human liver microsomes assessed as enzyme-mediated metabolite formation using dextromethorphan as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442995Inhibition of CYP2D6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 1 uM using dextromethorphan as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS ana2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1443004Inhibition of CYP3A4 in human liver microsomes assessed as enzyme-mediated metabolite formation at 10 uM using midazolam as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis 2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442973Inhibition of CYP2C8 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.3 uM using paclitaxel as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysi2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442890Inhibition of CYP2A6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.1 uM using coumarin as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442940Inhibition of CYP3A4 in human liver microsomes assessed as enzyme-mediated metabolite formation at 3 uM using midazolam as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442925Inhibition of CYP2C19 in human liver microsomes assessed as enzyme-mediated metabolite formation at 1 uM using (S)-mephenytoin as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442942Inhibition of CYP3A4 in human liver microsomes assessed as enzyme-mediated metabolite formation at 30 uM using midazolam as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442943Inhibition of CYP3A4 in human liver microsomes assessed as enzyme-mediated metabolite formation using midazolam as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1220001Cytotoxicity against human H1299 cells assessed as growth inhibition after 24 hrs by MTT assay2012Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 40, Issue:4
Metabolism of [6]-shogaol in mice and in cancer cells.
AID1442895Inhibition of CYP1A2 in human liver microsomes assessed as enzyme-mediated metabolite formation using phenacetin as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1477268Antagonist activity at Pseudomonas aeruginosa LasR expressed in Escherichia coli DH5alpha assessed as inhibition of protein interaction with OdDHL at 1 to 10 uM after 1.5 hrs by beta-galactosidase reporter gene assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Structure-Activity Relationships of 6- and 8-Gingerol Analogs as Anti-Biofilm Agents.
AID1442923Inhibition of CYP2C19 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.1 uM using (S)-mephenytoin as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442976Inhibition of CYP2C8 in human liver microsomes assessed as enzyme-mediated metabolite formation at 10 uM using paclitaxel as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1443012Inhibition of CYP3A4 in human liver microsomes assessed as enzyme-mediated metabolite formation at 30 uM using testosterone as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analys2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442933Inhibition of CYP2D6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 3 uM using dextromethorphan as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1443015Inhibition of human CYP2B6 using bupropion as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442914Inhibition of CYP2C8 in human liver microsomes assessed as enzyme-mediated metabolite formation at 30 uM using paclitaxel as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442968Inhibition of CYP2B6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 3 uM using bupropion as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis r2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442972Inhibition of CYP2C8 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.1 uM using paclitaxel as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysi2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442930Inhibition of CYP2D6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.1 uM using dextromethorphan as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1219960Induction of apoptosis in human H1299 cells assessed as apoptotic cells at 80 uM after 24 hrs by TUNEL assay2012Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 40, Issue:4
Metabolism of [6]-shogaol in mice and in cancer cells.
AID1442919Inhibition of CYP2C9 in human liver microsomes assessed as enzyme-mediated metabolite formation at 3 uM using diclofenac as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442910Inhibition of CYP2C8 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.3 uM using paclitaxel as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID676738Inhibition of Multidrug resistance efflux pump in Mycobacterium smegmatis str. MC2 155 ATCC 700084 assessed as reduction in ethidium bromide MIC presence of test compound at 16 mg/L2012Journal of natural products, Jul-27, Volume: 75, Issue:7
Putative mycobacterial efflux inhibitors from the seeds of Aframomum melegueta.
AID1442986Inhibition of CYP2C19 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.1 uM using (S)-mephenytoin as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS a2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442975Inhibition of CYP2C8 in human liver microsomes assessed as enzyme-mediated metabolite formation at 3 uM using paclitaxel as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis 2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442907Inhibition of CYP2B6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 30 uM using bupropion as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442970Inhibition of CYP2B6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 30 uM using bupropion as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis 2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442956Inhibition of CYP1A2 in human liver microsomes assessed as enzyme-mediated metabolite formation at 30 uM using phenacetin as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1443016Inhibition of human CYP2C8 using paclitaxel as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID676737Antimicrobial activity against Mycobacterium smegmatis str. MC2 155 ATCC 700084 incubated for 72 hrs in Mueller-Hinton broth medium by MTT assay2012Journal of natural products, Jul-27, Volume: 75, Issue:7
Putative mycobacterial efflux inhibitors from the seeds of Aframomum melegueta.
AID1442980Inhibition of CYP2C9 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.3 uM using diclofenac as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysi2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442971Inhibition of CYP2B6 in human liver microsomes using bupropion as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442961Inhibition of CYP2A6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 3 uM using coumarin as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis re2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442932Inhibition of CYP2D6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 1 uM using dextromethorphan as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID676744Inhibition of Multidrug resistance efflux pump in Mycobacterium smegmatis str. MC2 155 ATCC 700084 assessed as fractional inhibitory concentration index in presence of ethidium bromide2012Journal of natural products, Jul-27, Volume: 75, Issue:7
Putative mycobacterial efflux inhibitors from the seeds of Aframomum melegueta.
AID1442951Inhibition of CYP1A2 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.1 uM using phenacetin as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysi2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442955Inhibition of CYP1A2 in human liver microsomes assessed as enzyme-mediated metabolite formation at 10 uM using phenacetin as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442926Inhibition of CYP2C19 in human liver microsomes assessed as enzyme-mediated metabolite formation at 3 uM using (S)-mephenytoin as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442935Inhibition of CYP2D6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 30 uM using dextromethorphan as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442959Inhibition of CYP2A6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.3 uM using coumarin as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis 2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442903Inhibition of CYP2B6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.3 uM using bupropion as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1219996Drug level in human H1299 cells treated with 10 uM [6]-shogaol after 24 hrs by HPLC-ECD analysis2012Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 40, Issue:4
Metabolism of [6]-shogaol in mice and in cancer cells.
AID1442990Inhibition of CYP2C19 in human liver microsomes assessed as enzyme-mediated metabolite formation at 10 uM using (S)-mephenytoin as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS an2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442899Inhibition of CYP2A6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 10 uM using coumarin as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1443000Inhibition of CYP3A4 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.1 uM using midazolam as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID676745Inhibition of Multidrug resistance efflux pump in Mycobacterium smegmatis str. MC2 155 ATCC 700084 assessed as reduction in ethambutol bromide MIC presence of test compound at 16 mg/L2012Journal of natural products, Jul-27, Volume: 75, Issue:7
Putative mycobacterial efflux inhibitors from the seeds of Aframomum melegueta.
AID1442957Inhibition of CYP1A2 in human liver microsomes using phenacetin as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442982Inhibition of CYP2C9 in human liver microsomes assessed as enzyme-mediated metabolite formation at 3 uM using diclofenac as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis 2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID676754Inhibition of Multidrug resistance efflux pump in Mycobacterium smegmatis str. MC2 155 ATCC 700084 assessed as fractional inhibitory concentration index in presence of rifampicin2012Journal of natural products, Jul-27, Volume: 75, Issue:7
Putative mycobacterial efflux inhibitors from the seeds of Aframomum melegueta.
AID1442965Inhibition of CYP2B6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.1 uM using bupropion as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1443003Inhibition of CYP3A4 in human liver microsomes assessed as enzyme-mediated metabolite formation at 3 uM using midazolam as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis r2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442996Inhibition of CYP2D6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 3 uM using dextromethorphan as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS ana2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442947Inhibition of CYP3A4 in human liver microsomes assessed as enzyme-mediated metabolite formation at 3 uM using testosterone as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442928Inhibition of CYP2C19 in human liver microsomes assessed as enzyme-mediated metabolite formation at 30 uM using (S)-mephenytoin as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442952Inhibition of CYP1A2 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.3 uM using phenacetin as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysi2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID676751Inhibition of Multidrug resistance efflux pump in Mycobacterium smegmatis str. MC2 155 ATCC 700084 assessed as reduction in rifampicin bromide MIC presence of test compound at 16 mg/L2012Journal of natural products, Jul-27, Volume: 75, Issue:7
Putative mycobacterial efflux inhibitors from the seeds of Aframomum melegueta.
AID1442981Inhibition of CYP2C9 in human liver microsomes assessed as enzyme-mediated metabolite formation at 1 uM using diclofenac as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis 2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1219989Drug level in human HCT116 cells treated with 10 uM [6]-shogaol after 24 hrs by HPLC-ECD analysis2012Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 40, Issue:4
Metabolism of [6]-shogaol in mice and in cancer cells.
AID1442964Inhibition of CYP2A6 in human liver microsomes using coumarin as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442953Inhibition of CYP1A2 in human liver microsomes assessed as enzyme-mediated metabolite formation at 1 uM using phenacetin as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis 2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442909Inhibition of CYP2C8 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.1 uM using paclitaxel as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID676757Inhibition of Multidrug resistance efflux pump in Mycobacterium smegmatis str. MC2 155 ATCC 700084 assessed as increase in normalized ethidium bromide fluorescence efflux at 0.5 MIC level by fluorimetric assay2012Journal of natural products, Jul-27, Volume: 75, Issue:7
Putative mycobacterial efflux inhibitors from the seeds of Aframomum melegueta.
AID1442993Inhibition of CYP2D6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.1 uM using dextromethorphan as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS a2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID676755Inhibition of Multidrug resistance efflux pump in Mycobacterium smegmatis str. MC2 155 ATCC 700084 assessed as increase in relative ethidium bromide fluorescence accumulation at 0.5 MIC level by fluorimetric assay (Rvb = 6057.1 +/- 508.6 RFU)2012Journal of natural products, Jul-27, Volume: 75, Issue:7
Putative mycobacterial efflux inhibitors from the seeds of Aframomum melegueta.
AID1443018Inhibition of human CYP2C19 using (S)-mephenytoin as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442962Inhibition of CYP2A6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 10 uM using coumarin as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis r2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442892Inhibition of CYP1A2 in human liver microsomes assessed as enzyme-mediated metabolite formation at 3 uM using phenacetin as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442977Inhibition of CYP2C8 in human liver microsomes assessed as enzyme-mediated metabolite formation at 30 uM using paclitaxel as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1443006Inhibition of CYP3A4 in human liver microsomes using midazolam as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442889Inhibition of CYP1A2 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.3 uM using phenacetin as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442901Inhibition of CYP2A6 in human liver microsomes assessed as enzyme-mediated metabolite formation using coumarin as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442984Inhibition of CYP2C9 in human liver microsomes assessed as enzyme-mediated metabolite formation at 30 uM using diclofenac as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1477267Inhibition of static biofilm formation of Pseudomonas aeruginosa PA14 at 10 uM after 24 hrs by crystal violet staining-based assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Structure-Activity Relationships of 6- and 8-Gingerol Analogs as Anti-Biofilm Agents.
AID1442949Inhibition of CYP3A4 in human liver microsomes assessed as enzyme-mediated metabolite formation at 30 uM using testosterone as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442904Inhibition of CYP2B6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 1 uM using bupropion as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1443017Inhibition of human CYP2C9 using diclofenac as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442893Inhibition of CYP1A2 in human liver microsomes assessed as enzyme-mediated metabolite formation at 10 uM using phenacetin as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442950Inhibition of CYP3A4 in human liver microsomes assessed as enzyme-mediated metabolite formation using testosterone as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442898Inhibition of CYP2A6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 3 uM using coumarin as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442987Inhibition of CYP2C19 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.3 uM using (S)-mephenytoin as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS a2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442934Inhibition of CYP2D6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 10 uM using dextromethorphan as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442994Inhibition of CYP2D6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.3 uM using dextromethorphan as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS a2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442906Inhibition of CYP2B6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 10 uM using bupropion as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442896Inhibition of CYP2A6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.3 uM using coumarin as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442924Inhibition of CYP2C19 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.3 uM using (S)-mephenytoin as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442891Inhibition of CYP1A2 in human liver microsomes assessed as enzyme-mediated metabolite formation at 1 uM using phenacetin as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442989Inhibition of CYP2C19 in human liver microsomes assessed as enzyme-mediated metabolite formation at 3 uM using (S)-mephenytoin as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS ana2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442997Inhibition of CYP2D6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 10 uM using dextromethorphan as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS an2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442897Inhibition of CYP2A6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 1 uM using coumarin as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442917Inhibition of CYP2C9 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.3 uM using diclofenac as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442920Inhibition of CYP2C9 in human liver microsomes assessed as enzyme-mediated metabolite formation at 10 uM using diclofenac as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442902Inhibition of CYP2B6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.1 uM using bupropion as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1219981Drug level in C57BL/6J mouse feces treated with [6]-shogaol at 200 mg/kg, po by HPLC-ECD analysis relative to control2012Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 40, Issue:4
Metabolism of [6]-shogaol in mice and in cancer cells.
AID1442921Inhibition of CYP2C9 in human liver microsomes assessed as enzyme-mediated metabolite formation at 30 uM using diclofenac as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442941Inhibition of CYP3A4 in human liver microsomes assessed as enzyme-mediated metabolite formation at 10 uM using midazolam as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442888Inhibition of CYP1A2 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.1 uM using phenacetin as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1443009Inhibition of CYP3A4 in human liver microsomes assessed as enzyme-mediated metabolite formation at 1 uM using testosterone as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysi2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1443001Inhibition of CYP3A4 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.3 uM using midazolam as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442945Inhibition of CYP3A4 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.3 uM using testosterone as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442998Inhibition of CYP2D6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 30 uM using dextromethorphan as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS an2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442991Inhibition of CYP2C19 in human liver microsomes assessed as enzyme-mediated metabolite formation at 30 uM using (S)-mephenytoin as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS an2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442992Inhibition of CYP2C19 in human liver microsomes using (S)-mephenytoin as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1443008Inhibition of CYP3A4 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.3 uM using testosterone as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analy2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442954Inhibition of CYP1A2 in human liver microsomes assessed as enzyme-mediated metabolite formation at 3 uM using phenacetin as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis 2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442958Inhibition of CYP2A6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.1 uM using coumarin as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis 2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442983Inhibition of CYP2C9 in human liver microsomes assessed as enzyme-mediated metabolite formation at 10 uM using diclofenac as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442966Inhibition of CYP2B6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.3 uM using bupropion as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442916Inhibition of CYP2C9 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.1 uM using diclofenac as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442969Inhibition of CYP2B6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 10 uM using bupropion as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis 2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1219959Induction of apoptosis in human HCT116 cells assessed as apoptotic cells at 80 uM after 24 hrs by TUNEL assay2012Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 40, Issue:4
Metabolism of [6]-shogaol in mice and in cancer cells.
AID1442918Inhibition of CYP2C9 in human liver microsomes assessed as enzyme-mediated metabolite formation at 1 uM using diclofenac as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442931Inhibition of CYP2D6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 0.3 uM using dextromethorphan as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1443002Inhibition of CYP3A4 in human liver microsomes assessed as enzyme-mediated metabolite formation at 1 uM using midazolam as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis r2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID676741Inhibition of Multidrug resistance efflux pump in Mycobacterium smegmatis str. MC2 155 ATCC 700084 assessed as reduction in ciprofloxacin bromide MIC presence of test compound at 16 mg/L2012Journal of natural products, Jul-27, Volume: 75, Issue:7
Putative mycobacterial efflux inhibitors from the seeds of Aframomum melegueta.
AID1443005Inhibition of CYP3A4 in human liver microsomes assessed as enzyme-mediated metabolite formation at 30 uM using midazolam as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis 2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442913Inhibition of CYP2C8 in human liver microsomes assessed as enzyme-mediated metabolite formation at 10 uM using paclitaxel as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis relative to control2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442967Inhibition of CYP2B6 in human liver microsomes assessed as enzyme-mediated metabolite formation at 1 uM using bupropion as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS analysis r2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442988Inhibition of CYP2C19 in human liver microsomes assessed as enzyme-mediated metabolite formation at 1 uM using (S)-mephenytoin as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins in presence of NADPH by LC-MS/MS ana2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
AID1442922Inhibition of CYP2C9 in human liver microsomes assessed as enzyme-mediated metabolite formation using diclofenac as substrate incubated for 5 mins followed by NADPH addition measured after 30 mins by LC-MS/MS analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (25)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (8.00)18.2507
2000's5 (20.00)29.6817
2010's12 (48.00)24.3611
2020's6 (24.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.54

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.54 (24.57)
Research Supply Index3.33 (2.92)
Research Growth Index5.09 (4.65)
Search Engine Demand Index47.56 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.54)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (3.85%)5.53%
Reviews2 (7.69%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other23 (88.46%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]